Arrayit Corporation and TeleChem International Inc Celebrate 25 Years in Business
November 01 2018 - 5:30AM
Sunnyvale, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation
(OTC: ARYC), a life sciences and personalized medicine
company, announces that management and staff are commemorating its
25-year business anniversary. On November 1, 1993, with two
telephones and seed capital borrowed from their parents,
entrepreneurs Rene Schena and Todd Martinsky founded industrial and
specialty chemicals manufacturing and wholesale distribution
company TeleChem International, Inc in downtown San Jose,
California. After adding the microarray life sciences segment in
1997, TeleChem International grew to become the 11th
largest woman-owned business enterprise in Silicon Valley, and
joined the elite Inc 500 list of fastest-growing private companies
in the United States in 2002 and 2003. Arrayit Corporation became
publicly traded in 2009, making the chemicals division a
wholly-owned subsidiary. Today, Arrayit leverages its life sciences
and clinical expertise to commercialize healthcare tests for
allergy, dietary wellness, food safety and pipeline
indications for ovarian cancer and Parkinson’s Disease.
Arrayit recently completed an allergy testing pilot program for
a top retail chain, established a nationwide network of 1,700
allergy sales professionals, met with top officials at the United
States Food and Drug Administration (FDA) regarding approval of a
major product line, signed allergy testing contracts with a
consortium of 178 medical clinics, received approval for in-store
promotions by a major retailer, announced allergy testing
partnerships with major allergy therapeutics providers, received
approval for direct Medicare billing by the Centers for Medicare
and Medicaid Services (CMS), reported the sale and shipping of
clinical instrumentation to the FDA, aced three consecutive rounds
of proficiency testing with the College of American Pathologists,
and launched the Patient Data Solutions allergy portal for doctors
and clinics. The company’s breadth and depth of experience and
advanced microarray technology provide the foundation on which
these major new initiatives are being implemented.
Chief Executive Officer Rene Schena states, “This 25-year
milestone is a testament to our loyal customer base and trusted
suppliers around the world. We are very proud of our employees and
their entrepreneurial spirit. We wish to take this opportunity to
reflect upon our accomplishments, celebrate our successes to date,
and thank all of our shareholders and colleagues for their kind
support as we embrace the future.”
About Arrayit
Arrayit Corporation, headquartered in Sunnyvale, California, leads
and empowers the research, biotechnology, pharmaceutical, clinical
and healthcare sectors through the discovery, development and
manufacture of proprietary life science and personalized medicine
products and services to advance biomedical research and improve
wellness and human health. Please visit
www.arrayit.com for more information.
Safe Harbor Statement
We have identified forward-looking statements by using words such
as "expect", "believe", and "should". Although we believe our
expectations are reasonable, our operations involve a number of
risks and uncertainties that are beyond our control, and these
statements may turn out not to be true. Risk factors associated
with our business, including some of the facts set forth herein,
are detailed in the Company's public filings.
CONTACT
Public Relations
Arrayit Corporation
Tel: 408-744-1331
Email: arrayit@arrayit.com
Web: www.arrayit.com
CONTACT
Public Relations
Arrayit Corporation
Tel: 408-744-1331
Email: arrayit@arrayit.com
Web: www.arrayit.com
![Arrayit-Corporation-Logo.jpg](https://resource.globenewswire.com/media/4b8c703f-fa1a-47fc-9f13-33353c2664f3/small/arrayit-corporation-logo-jpg.jpg)
![](http://www.globenewswire.com/newsroom/ti?ndecode=MTA0ODcjNzQyMjYzNA==)
Arrayit (CE) (USOTC:ARYC)
Historical Stock Chart
From Jul 2024 to Aug 2024
Arrayit (CE) (USOTC:ARYC)
Historical Stock Chart
From Aug 2023 to Aug 2024